MicroLub: A novel microgel-based superlubricating formulation for fat replacement applications
MicroLub:一种基于微凝胶的新型超级润滑配方,适用于脂肪替代应用
基本信息
- 批准号:EP/X03514X/1
- 负责人:
- 金额:$ 16.47万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2023
- 资助国家:英国
- 起止时间:2023 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Reducing fat in foods is a viable strategy to significantly decrease calorie intake and thus, fat replacer molecules are likely to be important in the race towards reversing the obesity crisis. The commercial fat replacer market is expected to considerably increase to 24 billion Euros by 2027, largely fueled by the growing public awareness for reduced-fat foods. However, the fat replacer industry faces severe technological challenges because the currently marketed fat replacers do not fully emulate the lubrication performance of full fat counterparts and thus fail to achieve consumers' expectations. The aim of the MicroLub project is to translate an innovative microgel-based technology with superlubricity developed in the context of the ERC project LubSat, towards the development of a more effective fat replacer ingredient. The technological innovation proposed includes deformable polypeptide-based microgels with grafted saccharides in a patchy heterogenous morphology. The exposed polypeptide region lead to a transient colloidal coating of the oral surfaces via hydrophobic interactions, whilst the grafted saccharides hydrogen bond with water molecules to create a microporous hydrated scaffold. This technology thus combines boundary and fluid film lubrication, unachieved by any fat replacement technologies available to date. Working through 4 work-packages, we will validate the techno-commercial feasibility of the formulation in close cooperation with experienced industrial partners and create the framework for potential licensing of this breakthrough technology to key industrial players. The expected outcomes aim to demonstrate the up-scaling feasibility and validation of technical performance against competition, filing a licensable patent, and developing a provisional business model that will allow us to build strategic alliances with selected industrial partners to take forward the commercialization of this technology and finally contribute towards reducing obesity
减少食物中的脂肪是显着减少卡路里摄入量的可行策略,因此,脂肪替代分子可能在扭转肥胖危机的竞赛中发挥重要作用。预计到 2027 年,商业脂肪替代品市场将大幅增长至 240 亿欧元,这主要是由于公众对低脂食品的认识不断增强。然而,脂肪替代品行业面临着严峻的技术挑战,因为目前市售的脂肪替代品并未完全模仿全脂同类产品的润滑性能,因此未能达到消费者的期望。 MicroLub 项目的目标是将 ERC 项目 LubSat 中开发的具有超润滑性的创新微凝胶技术转化为开发更有效的脂肪替代成分。所提出的技术创新包括可变形的基于多肽的微凝胶,其具有斑片异质形态的接枝糖。暴露的多肽区域通过疏水相互作用在口腔表面形成短暂的胶体涂层,同时接枝的糖与水分子形成氢键以形成微孔水合支架。因此,该技术结合了边界润滑和液膜润滑,这是迄今为止任何脂肪替代技术都无法实现的。我们将通过 4 个工作包,与经验丰富的工业合作伙伴密切合作,验证该配方的技术商业可行性,并为这一突破性技术向主要工业参与者的潜在许可建立框架。预期成果旨在证明技术性能在竞争中的扩大可行性和验证、申请可授权专利并开发临时商业模式,使我们能够与选定的工业合作伙伴建立战略联盟,以推进该技术的商业化最终为减少肥胖做出贡献
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Glycation influencing lubrication: Tribology principles derived from nature to inspire future food colloid design
- DOI:10.1016/j.cocis.2023.101782
- 发表时间:2023-12-01
- 期刊:
- 影响因子:0
- 作者:A. Sarkar;Khalid Gul
- 通讯作者:Khalid Gul
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anwesha Sarkar其他文献
Correction: Relating rheology and tribology of commercial dairy colloids to sensory perception
- DOI:
10.1039/c7fo90006f - 发表时间:
2017-02 - 期刊:
- 影响因子:6.1
- 作者:
Laura Laguna;Grace Farrell;Michael Bryant;Ardian Morina;Anwesha Sarkar - 通讯作者:
Anwesha Sarkar
A standardised semi-dynamicin vitrodigestion method suitable for food – an international consensus
- DOI:
10.1039/c9fo01293a - 发表时间:
2020-02 - 期刊:
- 影响因子:6.1
- 作者:
Ana-Isabel Mulet-Cabero;Lotti Egger;Reto Portmann;Olivia Ménard;Sébastien Marze;Mans Minekus;Steven Le Feunteun;Anwesha Sarkar;Myriam M.-L. Grundy;Frédéric Carrière;Matt Golding;Didier Dupont;Isidra Recio;André Brodkorb;Alan Mackie - 通讯作者:
Alan Mackie
Correlating macroscopic plant growth parameters to nanomechanical properties of cellulose microfibrils
将宏观植物生长参数与纤维素微纤维的纳米力学特性相关联
- DOI:
10.1016/j.cpb.2024.100345 - 发表时间:
2024-04-01 - 期刊:
- 影响因子:5.4
- 作者:
Nabila Masud;Jie Tang;Hasibul Hasan Hasib;T. Jubery;Xuan Xuan Lee;Hongqing Guo;Anwesha Sarkar - 通讯作者:
Anwesha Sarkar
Extraction and characterization of carotenoid pigments with antioxidant and antibacterial potential from marine yeast Rhodotorula sp. KSB1.
从海洋酵母红酵母中提取和表征具有抗氧化和抗菌潜力的类胡萝卜素色素。
- DOI:
10.1007/s10123-024-00529-3 - 发表时间:
2024-05-15 - 期刊:
- 影响因子:0
- 作者:
Somak Banerjee;Anwesha Sarkar;K. V. B. Rao - 通讯作者:
K. V. B. Rao
Relating rheology and tribology of commercial dairy colloids to sensory perception
- DOI:
10.1039/c6fo01010e - 发表时间:
2016-09 - 期刊:
- 影响因子:6.1
- 作者:
Laura Laguna;Grace Farrell;Michael Bryant;Ardian Morina;Anwesha Sarkar - 通讯作者:
Anwesha Sarkar
Anwesha Sarkar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anwesha Sarkar', 18)}}的其他基金
PROTSENS Rethinking Alternative PROTein Extraction: Decoding SENsory-Protein Extraction Relationships
PROTSENS 重新思考替代性蛋白质提取:解码感觉-蛋白质提取关系
- 批准号:
EP/Z000785/1 - 财政年份:2024
- 资助金额:
$ 16.47万 - 项目类别:
Fellowship
相似国自然基金
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
- 批准号:82304658
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
- 批准号:82070530
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Targeted treatment of thrombotic occlusions using a dual-delivery microgel therapeutic
使用双重递送微凝胶治疗剂靶向治疗血栓闭塞
- 批准号:
10530989 - 财政年份:2022
- 资助金额:
$ 16.47万 - 项目类别:
Targeted treatment of thrombotic occlusions using a dual-delivery microgel therapeutic
使用双重递送微凝胶治疗剂靶向治疗血栓闭塞
- 批准号:
10223925 - 财政年份:2019
- 资助金额:
$ 16.47万 - 项目类别:
Targeted treatment of thrombotic occlusions using a dual-delivery microgel therapeutic
使用双重递送微凝胶治疗剂靶向治疗血栓闭塞
- 批准号:
10672059 - 财政年份:2019
- 资助金额:
$ 16.47万 - 项目类别:
Targeted treatment of thrombotic occlusions using a dual-delivery microgel therapeutic
使用双重递送微凝胶治疗剂靶向治疗血栓闭塞
- 批准号:
10457953 - 财政年份:2019
- 资助金额:
$ 16.47万 - 项目类别:
Targeted treatment of thrombotic occlusions using a dual-delivery microgel therapeutic
使用双重递送微凝胶治疗剂靶向治疗血栓闭塞
- 批准号:
10903125 - 财政年份:2019
- 资助金额:
$ 16.47万 - 项目类别: